| April 25, 2013 |
Amorfix to investigate lung cancer misfolded proteins for therapeutic intervention |
| April 22, 2013 |
Amorfix closes second tranche of private placement offering |
| April 9, 2013 |
Amorfix announces breakthrough scientific discovery and provides update for its ovarian cancer therapeutic antibody program |
| April 5, 2013 |
Amorfix closes private placement offering |
| April 3, 2013 |
Amorfix chief science officer to present latest on ovarian cancer therapeutic program at AACR 2013 |
| March 20, 2013 |
Amorfix announces progress on ALS program |
| February 21, 2013 |
Amorfix closes private placement offering |
| February 14, 2013 |
Amorfix announces third quarter fiscal 2013 results and financing |
| January 31, 2013 |
Pharmaceutical executive Warren Whitehead joins Amorfix as chief financial officer |
| January 29, 2013 |
Amorfix and QPS to collaborate on Alzheimer's disease project |
| January 24, 2013 |
Amorfix to present cancer therapeutic program at AACR 2013 |
| January 22, 2013 |
Amorfix provides update on ALS diagnostic program |
| January 4, 2013 |
Amorfix to present corporate overview at the Biotech Showcase 2013 Conference |